From heart failure and kidney dysfunction to cardiorenal syndrome: TMAO may be a bridge

The study of trimethylamine oxide (TMAO), a metabolite of gut microbiota, and heart failure and chronic kidney disease has made preliminary achievements and been summarized by many researchers, but its research in the field of cardiorenal syndrome is just beginning. TMAO is derived from the trimethy...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jialun Zhang, Peining Zhu, Siyu Li, Yufei Gao, Yue Xing
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2023-11-01
coleção:	Frontiers in Pharmacology
Assuntos:	trimethylamine oxide heart failure chronic kidney disease cardiorenal syndrome trimethylamine
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1291922/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!